179 results
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The Company
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(n) [RESERVED]
(o) Material
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The Company
8-K
EX-10.2
bwo1h900jfmc
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
424B3
tgzwxa2
7 Aug 23
Prospectus supplement
7:21am
8-K
EX-10.1
d8du0f4oxt8ykg8
9 Nov 22
Entry into a Material Definitive Agreement
8:30am